S020 Treating Severe Skin Diseases in Children
DESCRIPTION
During this session, attendees will review challenging topics faced in the pediatric population. Speakers will provide updates in the diagnosis and management of contact dermatitis, psoriasis and infantile hemangiomas. Learners will review and develop an approach to pediatric patients with malignancy, autoinflammatory disorders and alopecia areata. Speakers with answer audience questions during hourly Q&As.
LEARNING OBJECTIVES
Diagnose inherited, inflammatory, infectious and autoimmune dermatologic diseases in children.
Select systemic, topical and other therapies for severe skin disease in children.
Develop an approach to managing children with severe skin disease.
SCHEDULE
1:00 PM
Systemic Therapy for Pediatric Psoriasis: Approach to Clinical Decision Making
Kelly M. Cordoro, MD, FAAD
1:25 PM
Top 10 Tips for Caring for Kids with Cancer
Jennifer T. Huang, MD, FAAD
1:50 PM
Q&A
Kelly M. Cordoro, MD, FAAD, Jennifer T. Huang, MD, FAAD
2:00 PM
Decoding Pediatric Contact Dermatitis
Kari Martin, MD, FAAD
2:25 PM
Finding and Managing Needles in Haystacks
Leslie Castelo-Soccio, MD, PhD, FAAD
2:50 PM
Q&A
Leslie Castelo-Soccio, MD, PhD, FAAD, Kari Martin, MD, FAAD
3:00 PM
Our Amazing Patients: Lessons Learned in the Twin Cities
Sheilagh M. Maguiness, MD, FAAD
3:25 PM
Updates on Systemic Management of Pediatric Alopecia Areata
Brittany Gareth Craiglow, MD, FAAD
3:50 PM
Q&A
Brittany Gareth Craiglow, MD, FAAD, Sheilagh M. Maguiness, MD, FAAD
DIRECTOR
Christine T Lauren, MD, FAAD
CO-DIRECTOR
Kari Martin, MD, FAAD
SPEAKERS
Leslie Castelo-Soccio, MD, PhD, FAAD
Kelly M. Cordoro, MD, FAAD
Brittany Gareth Craiglow, MD, FAAD
Jennifer T. Huang, MD, FAAD
Sheilagh M. Maguiness, MD, FAAD
HANDOUTS
DISCLOSURES
Leslie Castelo-Soccio, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Kelly M. Cordoro, MD, FAAD
No financial relationships exist with ineligible companies.
Brittany Gareth Craiglow, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Speaker(Fees); BiologicsMD, Inc. – Consultant (1099 relationship)(Fees); Concert Pharmaceuticals – Consultant(Grants/Research Funding); CorEvitas – Consultant (1099 relationship)(Fees); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Consultant(Fees), Speaker(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte – Advisory Board(Fees); Incyte Corporation – Speaker(Honoraria); Leo Pharma – Advisory Board(Fees); Novartis – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees), Investigator(No Compensation Received), Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees);
Jennifer T. Huang, MD, FAAD
Day One Biopharmaceuticals – Advisory Board(Honoraria); EllaOla – Advisory Board(Fees); Sanofi – Advisory Board(Honoraria), Data Safety Monitoring Board(Honoraria);
Christine T Lauren, MD, FAAD
No financial relationships exist with ineligible companies.
Sheilagh M. Maguiness, MD, FAAD
DYPER – Other(Fees); Galderma – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Stryke Club LLC – Founder(No Compensation Received);
Kari Martin, MD, FAAD
American Contact Dermatitis Society – Other(No Compensation Received); National Eczema Association – Consultant (1099 relationship)(Honoraria); Women's Dermatologic Society – Board of Directors(No Compensation Received);